https://www.selleckchem.com/pr....oducts/Gemcitabine-H
The invivo dosimetric monitoring in HDR brachytherapy is important for improving patient safety. However, there are very limited options available for clinical application. In this study, we present a new invivo dose measurement system with a plastic scintillating detector (PSD) for GYN HDR brachytherapy. An FDA approved PSD system, called OARtrac (AngioDynamics, Latham, NY), was used with various applicators for invivo dose measurements for GYN patients. An institutional workflow was established for the clinic
Like
Comment
Share
